- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05281744
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias (Co-CARE-AD)
July 31, 2023 updated by: Xiaojuan Li, Harvard Pilgrim Health Care
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias (Co-CARE-AD)
This is a randomized, pragmatic clinical trial to evaluate the effectiveness of a collaborative care-coordination program embedded in a health plan for people living with Alzheimer's disease and related dementias (ADRD) and their care partners versus usual care.
The study population will include community-dwelling Medicare Advantage members living with ADRD and their care partners.
Outcomes will be healthcare utilization outcomes of individuals with ADRD and include emergency department visits, outpatient visits, avoidable emergency department visits, and admission to long-term care facilities.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
2160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Katie Haffenreffer
- Phone Number: 617-867-4807
- Email: katie_haffenreffer@harvardpilgrim.org
Study Contact Backup
- Name: Audrey Wolfe
- Email: audrey_wolfe@harvardpilgrim.org
Study Locations
-
-
Massachusetts
-
Watertown, Massachusetts, United States, 02472
- Tufts Health Plan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Community-dwelling Tufts Health Plan Medicare Advantage members with ADRD and their caregivers will be selected to participate in the trial based on the following inclusion/exclusion criteria:
Inclusion Criteria (for members with ADRD)
- Member of Tufts Health Plan Medicare Advantage plan
- Medical and pharmacy insurance coverage in at least the prior 12 months
- Have ≥1 ICD-10-CM diagnosis code for ADRD or dispensing for pharmacological treatment for ADRD in the prior 12 months
Exclusion Criteria (for members with ADRD):
- Reside in a nursing home or skilled nursing facility
- Enrolled in a hospice program
- Receiving or have received the Dementia Care Consultation program as part of the existing program at the time of enrollment
Inclusion Criteria (for caregivers)
- Age 18 years or older
- Assume primary responsibility for members
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dementia Care Consultation program
The Dementia Care Consultation program provides an in-depth, personalized service for individuals and families facing ADRD.
|
The Dementia Care Consultation program uses a telephone-based intervention to provide an in-depth, personalized service for individuals living with ADRD and their care partners.
It consists of comprehensive needs assessments, creation and implementation of personalized care plans, monitoring and revising care plans, disease education and support coaching, referrals to community-based organizations for service and support, and access to assistance.
|
No Intervention: Routine Care
Members randomized into the control group will receive routine care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause emergency department visits
Time Frame: by 12 months
|
Number of all-cause emergency department visits per member living with ADRD over the 12-month follow-up period.
|
by 12 months
|
All-cause emergency department visits
Time Frame: by 6 months
|
Number of all-cause emergency department visits per member living with ADRD over the 6-month follow-up period.
|
by 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outpatient visits
Time Frame: by 12 months
|
Number of outpatient visits per member living with ADRD over the 12-month follow-up period.
|
by 12 months
|
Outpatient visits
Time Frame: by 6 months
|
Number of outpatient visits per member living with ADRD over the 6-month follow-up period.
|
by 6 months
|
Avoidable emergency department visits
Time Frame: by 12 months
|
Number avoidable emergency department visits (defined using the validated New York University ED visit algorithm) per member living with ADRD over the 12-month follow-up period.
|
by 12 months
|
Avoidable emergency department visits
Time Frame: by 6 months
|
Number avoidable emergency department visits (defined using the validated New York University ED visit algorithm) per member living with ADRD over the 6-month follow-up period.
|
by 6 months
|
Admission to long-term care facilities
Time Frame: by 12 months
|
Number of members living with ADRD with the first admission to long-term care facilities over the 12-month follow-up period.
|
by 12 months
|
Admission to long-term care facilities
Time Frame: by 6 months
|
Number of members living with ADRD with the first admission to long-term care facilities over the 6-month follow-up period.
|
by 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Xiaojuan Li, PhD MSPH, Harvard Pilgrim Health Care Institute
- Principal Investigator: Richard Platt, MD MS, Harvard Pilgrim Health Care Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 27, 2022
Primary Completion (Estimated)
October 25, 2024
Study Completion (Estimated)
March 28, 2025
Study Registration Dates
First Submitted
February 25, 2022
First Submitted That Met QC Criteria
March 7, 2022
First Posted (Actual)
March 16, 2022
Study Record Updates
Last Update Posted (Actual)
August 1, 2023
Last Update Submitted That Met QC Criteria
July 31, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AH000843
- 5U54AG063546-03 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease and Related Dementias (ADRD)
-
Indiana UniversityNational Institute on Aging (NIA)RecruitingAlzheimer Disease and Related Dementias (ADRD)United States
-
Indiana UniversityNational Institute on Aging (NIA)RecruitingAlzheimer Disease and Related Dementias (ADRD)United States
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA)Not yet recruitingAlzheimer's Disease and Related Dementias
-
Northwell HealthNational Institute of Nursing Research (NINR); Penn State UniversityCompletedAlzheimer's Disease and Related DementiasUnited States
-
Penn State UniversityRecruitingAlzheimer's Disease and Related DementiasUnited States
-
University of IowaNational Institute on Aging (NIA)Completed
-
Northwell HealthNational Institute of Nursing Research (NINR); Penn State UniversityCompletedAlzheimer's Disease and Related DementiasUnited States
-
Florida State UniversityNational Institute of Nursing Research (NINR)CompletedAlzheimer's Disease and Related DementiasUnited States
-
Arizona State UniversityRecruitingAlzheimer's Disease and Related Dementias Family CaregiversUnited States
-
Massachusetts General HospitalNational Institute on Aging (NIA); University of California, San FranciscoRecruitingQuality of Life | Caregiver Stress | Alzheimer's Disease and Related DementiasUnited States
Clinical Trials on Dementia Care Consultation program
-
Indiana UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedDementia | Mild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Tzu Chi University of Science and TechnologyCompletedDementia Family CaregiverTaiwan
-
Indiana UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA)Completed
-
Corporal Michael J. Crescenz VA Medical CenterCompleted
-
NYU Langone HealthNational Institute on Aging (NIA)Active, not recruitingDementiaUnited States
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
National Taiwan University HospitalCompletedEsophageal CancerTaiwan
-
Saint John's Cancer InstituteWithdrawnCancer | Caregivers | Clinical TrialsUnited States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Health... and other collaboratorsUnknown
-
Tri-Service General HospitalCompleted